infect
middl
east
respiratori
syndrom
coronaviru
merscov
associ
sever
morbid
mortal
treatabl
current
avail
antivir
therapi
recent
studi
shown
dna
vaccin
target
spike
protein
merscov
protect
infect
anim
model
includ
nonhuman
primat
could
use
develop
prevent
strategi
region
affect
viru
merscov
emerg
coronaviru
distinct
sever
acut
respiratori
syndrom
sar
cov
show
high
level
genet
divers
link
death
arabian
peninsula
europ
unit
state
humantohuman
transmiss
document
syndrom
present
acut
lower
respiratori
tract
infect
caus
sever
pneumonia
current
studi
muthumani
et
al
focus
protein
cov
main
envelop
protein
surfac
viru
gener
consensu
sequenc
vaccin
team
analys
protein
genom
sequenc
contain
genbank
databas
us
nation
institut
health
construct
design
includ
sequenc
cov
clade
b
help
ensur
broad
coverag
well
modif
increas
vivo
express
western
blot
immunofluoresc
assay
confirm
vitro
express
protein
cell
transfect
mer
vaccin
plasmid
mice
inject
intramuscularli
vaccin
three
time
interv
cellmedi
immun
elev
week
later
cell
immun
mice
secret
tumour
necrosi
factor
cell
vehicletr
mice
measur
flow
cytometri
analysi
serum
sampl
immun
reveal
vaccin
induc
product
proteinspecif
neutral
antibodi
rhesu
macaqu
show
similarli
encourag
cellular
humor
respons
vaccin
importantli
sera
immun
macaqu
show
neutral
activ
protein
variou
isol
across
merscov
clade
suggest
vaccin
could
prevent
immun
escap
genet
variat
pathogen
therebi
provid
broad
protect
immun
also
protect
macaqu
respiratori
patholog
alveolar
oedema
infiltr
inflammatori
cell
caus
merscov
challeng
week
treatment
camel
thought
repres
reservoir
merscov
middl
east
rout
transmiss
human
current
studi
muthumani
et
al
show
dna
vaccin
also
induc
neutral
antibodi
camel
suggest
applic
multipart
prevent
strategi
